Navigation Links
Genetic Variant Slows AIDS Progression
Date:11/23/2009

HIV patients who have it take longer to get sick, study finds

MONDAY, Nov. 23 (HealthDay News) -- Scientists report that a genetic variation appears to play a major role in slowing disease progression in HIV-infected patients.

In fact, those with the variation appear to take years longer to develop AIDS and die of complications of the disease.

"We're honing in on factors that vary across individuals that make a person more or less susceptible to HIV, in terms of how rapidly someone develops the disease," said study co-author Mary Carrington, a senior principal investigator at the U.S. National Cancer Institute.

However, this new knowledge won't translate into immediate benefits for patients with HIV.

AIDS remains a major killer in many parts of the world, but HIV -- the virus that causes it -- doesn't affect infected people the same way. "People progress to AIDS at hugely different rates," Carrington explained. "Some people progress within a year, while some have been infected for 20 years and still control the virus and don't have the disease."

It appears that three factors affect how the disease strikes a person, she said. One is the environment: the world in which a person lives. Another is the patient's genetic makeup. And the third is the genetic makeup of the virus itself.

In the study, published in the Nov. 22 online edition of Nature Genetics, Carrington and colleagues looked at genetic and medical records for hundreds of HIV-infected men. They were trying to see if genetic variations affected how the men fared.

The researchers found that a variation linked to higher levels of a protein known as HLA-C boosted the men's ability to avoid progressing to AIDS. It appeared to delay both the progression to AIDS and to death by years, Carrington said.

The genetic variation makes it easier for the immune system to kill cells that have been infected with the virus, she said. It does this by allowing immune cells to gain greater access to the infected cells, she explained.

Carrington said this genetic variation isn't related to another gene-related trait that makes some people virtually immune to HIV.

The study "hints at ways we might ultimately develop a vaccine or immune-based therapies that could modify or maybe even prevent the development of HIV disease," said Rowena Johnston, vice president of research with the Foundation for AIDS Research in New York City.

"The finding that a single piece of DNA can be strongly associated with something as complex as the control of HIV soon after infection is especially intriguing, not least because we know that early control of infection sets the stage for the entire course of the disease," Johnston noted.

What's next? The ultimate goal, Carrington said, is "to have a complete list of every genetic variance that is affecting how rapidly the disease develops."

That, in turn, could help physicians figure out how to better treat patients.

More information

Learn more about AIDS from AIDS.gov.



SOURCES: Mary Carrington, Ph.D., senior principal investigator, National Cancer Institute, Frederick, Md.; Rowena Johnston, Ph.D., vice president, research, Foundation for AIDS Research, New York City; Nov. 22, 2009, Nature Genetics, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Genetic changes shown to be important indicators for disease progression in cervical cancer patients
2. Cleveland Clinic Cancer Geneticist Charis Eng, M.D., Ph.D., Named To Federal Advisory Committee
3. Research Findings Key for Understanding, Interpreting Genetic Testing for Long QT Syndrome
4. Geneticists hunt for scleroderma triggers
5. Researchers exploit genetic co-dependence to kill treatment-resistant tumor cells
6. Research partnership will study how electronic medical records can address genetics of drug safety
7. Are Commercial Genetic Tests Worth Taking?
8. Genetics of patterning the cerebral cortex
9. Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings
10. Ironing out the genetic cause of hemoglobin problems
11. Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ... patients after receiving cognitive rehabilitation, according to a study released today at the ... that cognitive rehabilitation programs are proven to be effective in improving cognitive function ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, ... Go. Core benefits and advantages built into the home office sit stand solution ... and feel. Ability to gain the benefits embedded in the TaskMate Go are ...
(Date:2/24/2017)... ... 24, 2017 , ... WHAT: , The New Jersey Tech ... well as advocacy for the state and region‘s technology businesses, hosted their 2017 ... Council's Innovation Forecast event highlights innovation throughout the region from small to large ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only ... jobs in the United States may be taken over by technology in the next ... who steamrolls over colleagues is drawing to a close. Success will belong to those ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Healthcare Associates ... Medical Center at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, ... with easy access to Highway 121. , As the practice has grown, the need ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 24, 2017 Research and Markets has ... & Trends - Industry Forecast to 2025" report to their ... The ... of around 23.8% over the next decade to reach approximately $330.5 ... estimates and forecasts for all the given segments on global as ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Dry eye ... ... eye Drugs Price Analysis and Strategies - 2016, provides drug pricing data ... the following questions: What are the key ... positioned in the Global Dry eye market? What are ...
(Date:2/24/2017)... NEW YORK , Feb. 24, 2017 ... Monteverde & Associates PC , a boutique securities ... New York City , announces that a ... of Massachusetts  against Inotek Pharmaceuticals ... purchasers of the Company,s securities between July 23, 2015 and ...
Breaking Medicine Technology: